ArticleLung2024

Utility of the 52-Gene Risk Score to Identify Patients with Idiopathic Pulmonary Fibrosis at Greater Risk of Mortality in the Era of Antifibrotic Therapy.

Julia F Söllner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.